Skip to main content
. 2016 Oct 20;7(46):76181–76196. doi: 10.18632/oncotarget.12771

Table 4. Dose response matrix of BKM120+TKI2598 combination in PC3 cells.

BKM120
Conc (μM) 50 25 12.5 6.25 3.12 1.56 0.78 0.39
TKI258 Viability (%) 1% 8% 36% 39% 42% 64% 78% 84%
50 4% 3.92 2.57 1.89 1.55 1.39 1.30 1.25 1.23
25 15% 2.62 1.61 1.14 0.88 0.76 0.71 0.69 0.65
12.5 26% 2.38 1.42 0.96 0.67 0.56 0.48 0.47 0.43
6.25 51% 2.29 1.33 0.75 0.49 0.34 0.28 0.24 0.24
3.12 67% 2.04 1.08 0.60 0.35 0.23 0.17 0.13 0.13
1.56 76% 1.69 0.89 0.48 0.26 0.16 0.13 0.12 0.12
0.781 83% 1.54 0.78 0.39 0.21 0.14 0.11 0.09 0.26
0.39 93% 1.48 0.76 0.39 0.23 0.13 0.12 0.15 0.03

graphic file with name oncotarget-07-76181-i001.jpg Antagonism (CI > 1, red)

graphic file with name oncotarget-07-76181-i002.jpg Additive (CI = 1, yellow)

graphic file with name oncotarget-07-76181-i003.jpg Synergism (CI < 1, green)